More Value to Ophthalmic Innovators Working with Strategic Investors

Evan Norton of Abbott Ventures sees a trend in which corporate investors are moving up their game to an earlier development stage, which could result in more funding opportunities for innovators. “As a strategic investor, we don’t invest in things unless we see a path for them to be acquired by Abbott. We do, however,…

Read More

Funding Ophthalmology Innovation: The Focus of Science and Capital

Ophthalmology is a growing, but challenging, market. Innovation is abounding in its research stages and some people in the know foresee more positive development in breakthrough technologies by 2020, while delivering drugs to the back of the eye is up front in the minds and agendas of investors and innovators. Market data and dialogue indicate…

Read More